Mr. Sherburn is a 58 yo man with a history of Hodgkins lymphoma who underwent radiation therapy, hypertension, and non-Q wave MI and was admitted to LMC for cardiac catheterization and observation s/p cath. During the procedure, a chronic total occlusion of the proximal L.circumflex artery with collaterals to distal vessels was observed, as well as an RCA ostial discrete 45% lesion. Mr. Muthart tolerated the procedure well without adverse event or complication at the groin site, remaining afebrile, with stable electrolytes, hematocrit and WBC. EKG was without evidence of acute ischemia and cardiac enzymes remained flat, with his SBP running in the 90's to low 100's and his Lisinopril was decreased as a result. Imdur was also added to his cardiac regimen. The discharge medications were ALBUTEROL INHALER 2 PUFF INH QID PRN SOB, ECASA ( ASPIRIN ENTERIC COATED ) 325 MG PO QD, ATENOLOL 50 MG PO QD Food/Drug Interaction Instruction, LISINOPRIL 5 MG PO QD, NITROGLYCERIN 1/150 ( 0.4 MG ) 1 TAB SL Q5 MIN X 3 PRN Chest Pain HOLD IF: SBP&lt;[ ], TERBUTALINE ( TERBUTALINE SULFATE ) 5 MG PO QID, AZMACORT ( TRIAMCINOLONE ACETONIDE ) 2 PUFF INH QID, KEFLEX ( CEPHALEXIN ) 500 MG PO QID, and IMDUR ( ISOSORBIDE MONONIT.( SR ) ) 30 MG PO QD Food/Drug Interaction Instruction. Mr. Sherburn was discharged to home with a code status of full code and a diet of House / Low chol/low sat. fat, and was instructed to return to work after an appointment with a local physician. Follow up appointments with Dr. Ned Wendt (Cardiology 3/30/01), and Dr. Elias Forgey (SMH) were scheduled, and allergies to shellfish and morphine were reported.
Has patient ever been prescribed ecasa ( aspirin enteric coated )
ECASA ( ASPIRIN ENTERIC COATED ) 325 MG PO QD,